Immunovant
IMVT
$24.12
Share price
-7.60%
Change (1 day)
-49.59%
Change (1 year)
Categories
Earnings for Immunovant (IMVT)
Earnings in 2024 (TTM): -A$0.62 Billion
According to Immunovant's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunovant from 2019 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -A$0.68 Billion | 59.79% |
| 2023 | -A$0.42 Billion | 32.6% |
| 2022 | -A$0.32 Billion | 39.55% |
| 2021 | -A$0.23 Billion | 37.3% |
| 2020 | -A$0.17 Billion | 780.74% |
| 2019 | -A$18.75 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -A$0.24 Billion | -64.74% | 🇺🇸 USA |